I agree that this site is using cookies. You can find further informations here.
X
Brüggemann, Roger J.
278  results:
?
1

Clinical presentation and outcome of invasive mould disease..:

Bury, Didi ; Parmentier, Corline E.J. ; Tissing, Wim J.E....
EJC Paediatric Oncology.  3 (2024)  - p. 100143 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Dosing of IV posaconazole to treat critically ill patients ..:

Elkayal, Omar ; Mertens, Beatrijs ; Wauters, Joost...
Journal of Antimicrobial Chemotherapy.  79 (2024)  7 - p. 1645-1656 , 2024
Link: https://doi.org/10.1093/..
 
?
3

A protocol for an international, multicentre pharmacokineti..:

Roberts, Jason A. ; Sime, Fekade ; Lipman, Jeffrey...
Critical Care and Resuscitation.  25 (2023)  1 - p. 1-5 , 2023
Link: https://doi.org/10.1016/..
 
?
4

In reply to comment on 'Therapeutic drug monitoring-guided ..:

Veringa, Anette ; Brüggemann, Roger J. ; Alffenaar, Jan-Willem C.
International Journal of Antimicrobial Agents.  62 (2023)  2 - p. 106854 , 2023
Link: https://doi.org/10.1016/..
 
?
5

Corrigendum to 'The battle against fungi lessons in antifun..:

Kanj, Souha S. ; Haddad, Sara F. ; Meis, Jacques F....
International Journal of Antimicrobial Agents.  62 (2023)  2 - p. 106901 , 2023
Link: https://doi.org/10.1016/..
 
?
6

Meta-pharmacokinetic analysis of posaconazole following dos..:

Chen, Lu ; Krekels, Elke H.J. ; Dong, Yalin...
International Journal of Antimicrobial Agents.  62 (2023)  6 - p. 106995 , 2023
Link: https://doi.org/10.1016/..
 
?
7

The battle against fungi: lessons in antifungal stewardship..:

Kanj, Souha S. ; Haddad, Sara F. ; Meis, Jacques F....
International Journal of Antimicrobial Agents.  62 (2023)  1 - p. 106846 , 2023
Link: https://doi.org/10.1016/..
 
?
8

An update on drug-drug interactions for care of the acutely..:

Patanwala, Asad E ; Jager, Nynke G L ; Radosevich, John J.
American Journal of Health-System Pharmacy.  80 (2023)  19 - p. 1301-1308 , 2023
Link: https://doi.org/10.1093/..
 
?
9

An Integrated Population Pharmacokinetic Analysis for Posac..:

Chen, Lu ; Krekels, Elke H. J. ; Heijnen, Anne R...
Drugs.  83 (2023)  1 - p. 75-86 , 2023
Link: https://doi.org/10.1007/..
 
?
10

Deep tissue exposure of antibiotics at the target site of i..:

Bernts, Lucas H.P. ; Brüggemann, Roger ; Jansen, Anouk M.E....
Journal of Hepatology.  78 (2023)  - p. S973-S974 , 2023
Link: https://doi.org/10.1016/..
 
?
11

Therapeutic drug monitoring-guided treatment versus standar..:

Veringa, Anette ; Brüggemann, Roger J. ; Span, Lambert F.R....
International Journal of Antimicrobial Agents.  61 (2023)  2 - p. 106711 , 2023
Link: https://doi.org/10.1016/..
 
?
12

595. Olorofim (OLO) for treatment of invasive mould infecti..:

Cornelissen, Karen ; Wright, James G ; Cristinacce, Andrew...
Open Forum Infectious Diseases.  9 (2022)  Supplement_2 - p. , 2022
Link: https://doi.org/10.1093/..
 
?
13

Exposure to intravenous posaconazole in critically ill pati..:

Van Daele, Ruth ; Wauters, Joost ; Dreesen, Erwin...
Mycoses.  65 (2022)  6 - p. 656-660 , 2022
Link: https://doi.org/10.1111/..
 
?
14

Effects of dalteparin on anti‐Xa activities cannot be predi..:

van der Heijden, Charlotte D. C. C. ; ter Heine, Rob ; Kooistra, Emma J....
British Journal of Clinical Pharmacology.  88 (2022)  6 - p. 2982-2987 , 2022
Link: https://doi.org/10.1111/..
 
?
15

Management of drug–drug interactions of targeted therapies ..:

Brüggemann, Roger J ; Verheggen, Rebecca ; Boerrigter, Emmy...
The Lancet Haematology.  9 (2022)  1 - p. e58-e72 , 2022
Link: https://doi.org/10.1016/..
 
1-15